4,624
edits
Zyprexa: Difference between revisions
some structured data added
(some structured data added) |
|||
| Line 4: | Line 4: | ||
| wiki_recentchanges_URL = No | | wiki_recentchanges_URL = No | ||
| wiki_wikinode_URL = No | | wiki_wikinode_URL = No | ||
| wiki_status = | | wiki_status = Active | ||
| wiki_language = | | wiki_language = English | ||
| wiki_editmode = | | wiki_editmode = LoginToEdit | ||
| wiki_engine = | | wiki_engine = Pbwiki | ||
| wiki_maintopic = | | wiki_maintopic = Medical | ||
}} | }} | ||
==Description== | ==Description== | ||
{{add}} | {{add}} | ||
For the past few years, there has been some controversy about the drug Zyprexa. What we all know is that Zyprexa is an "atypical" neuroleptic (also known as an "anti-psychotic"), approved to treat schizophrenia and acute mania. At about $2.50/pill, it is a big money maker for Eli Lilly, somewhere on the order of $4 Billion a year. By themselves these facts are not controversial. | For the past few years, there has been some controversy about the drug {{tag|Zyprexa}}. What we all know is that Zyprexa is an "atypical" neuroleptic (also known as an "anti-psychotic"), approved to treat schizophrenia and acute mania. At about $2.50/pill, it is a big money maker for Eli Lilly, somewhere on the order of $4 Billion a year. By themselves these facts are not controversial. | ||
However, it seems that some internal memos indicate that Eli Lilly knew that the drug raised the risk of diabetes in patients and didn't act appropriately. They may have even misreported clinical trial data about blood-sugar risks to doctors. There is currently a class action lawsuit underway to hold Lilly accountable. These memos indicate that Lilly initiated an internal marketing campaign to willfully downplay these deleterious effects. | However, it seems that some internal memos indicate that Eli Lilly knew that the drug raised the risk of diabetes in patients and didn't act appropriately. They may have even misreported clinical trial data about blood-sugar risks to doctors. There is currently a class action lawsuit underway to hold Lilly accountable. These memos indicate that Lilly initiated an internal marketing campaign to willfully downplay these deleterious effects. | ||